Diagonal Bio announces strategic pilot study with Löberöds Hästklinik
Regulatory
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) is pleased to announce a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement, set to last an initial term of three months, will involve a pilot testing program focused on utilizing Diagonal Bio’s platform technology, LAMPlify®, for the detection of respiratory viral infections in sporthorses.
The Board of Directors and CEO of Diagonal Bio AB hereby publish the Annual Report for the fiscal year 2023. The Annual Report is available as an attached file to this release and on Diagonal Bio’s website (www.diagonalbio.com/investors/financial-reports).
Aktieägarna i Diagonal Bio AB (publ), org.nr 559248-8984, (”Bolaget”) kallas härmed till årsstämma tisdagen den 11 juni 2024 kl. 13.00. Stämman hålls på Medicon Village, Scheeletorget 1 i Lund.
Diagonal Bio AB announces last day of trading in BTU and first day of trading in TO 1
Regulatory
Diagonal Bio AB’s (“Diagonal Bio” or the “Company”) rights issue of units, with a subscription period ending on April 22, 2024, has now been registered at the Swedish Companies Registration Office. The Company hereby announces that the last day of trading in BTU (paid subscribed unit) is 13 May 2024, and the stop day is 15 May 2024. The first day of trading in warrants of series TO 1 is 17 May 2024.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM SWEDISH LAW. SEE THE “IMPORTANT INFORMATION” SECTION AT THE END OF THIS PRESS RELEASE. The subscription period in Diagonal Bio AB’s (“Diagonal Bio” or “the Company”) rights issue of units ended on the 22nd of April 2024. The rights issue was subscribed to a total of approximately 19.1 percent, including pre-subscription commitments, meaning that guarantee commitments of a total of approximately 37.3 percent were activated to achieve a total subscription rate of 56.4 percent. Diagonal Bio will thus be provided proceeds of approximately SEK 18 million before the deduction of transaction related costs.
We may request cookies to be set on your device. We use cookies to let us know how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
